Abstract
6531Background: Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukemia (CML) from a deadly cancer to chronic disease. While these drugs dramatically improve survival, non-adher...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
